Research Advisory Panel

Neuroendocrine Cancer Research Advisory Committee

NeuroEndocrine Cancer Australia is dedicated to improving patient outcomes through promoting and supporting unique Australian Neuroendocrine Cancer Research and participating in worthy research projects.

Prof Nick Pavlakis

Prof Nick Pavlakis is a Senior Staff Specialist in the Department of Medical Oncology at Royal North Shore Hospital. He has more than 25 years’ experience in the treatment and research of NETs, gastrointestinal cancers and thoracic cancers. Nick is the lead of the Sydney ENETs centre of excellence based at Royal North Shore Hospital, accredited since 2019, and a past president of COSA. Nick led the CONTROL NETs trial, has published numerous research articles, and given international presentations in NENs.
Read bio

Prof Michael Michael

Prof Michael is a Gastrointestinal (GI) and Neuroendocrine (NEN) Medical Oncologist at the Peter MacCallum Cancer Centre (PMCC); Clinical/Trial Lead for the Upper Gastrointestinal Medical Oncology Service; Co-Chair of the PMCC European Neuroendocrine Tumour Society (ENETs) accredited NET Centre of Excellence; and Professorial Fellow at The University of Melbourne Michael’s research represents a very close collaboration with institutional and outside medical specialists, and laboratory scientists in GI/NET oncology with regards to the clinical trial design and coordination of parallel translational studies to achieve optimisation of patient treatment. His research work and collaborations have generated over $23 million in competitive funding…
Read bio

A/Prof Grace Kong

Associate Professor, Sir Peter MacCallum Department of Oncology University of Melbourne. Nuclear Medicine Physician, Peter MacCallum Cancer Centre (PMCC) Melbourne Australia. Grace Kong’s leadership roles include the Lead of Radionuclide Therapy Service at PMCC overseeing a high-volume clinical theranostics service, Co-Chair of the PMCC NET Service an ENETS Centre of Excellence, Chair of the PRRT NET multidisciplinary meeting (MDM), and the Nuclear Medicine Lead for the Upper Gastrointestinal tumour MDM stream. She is the current Vice-President and Chair of the Medical Group of the ANZSNM (Australian New Zealand Society of Nuclear Medicine), member of the Australasian Association of Nuclear Medicine…
Read bio

Dr Piyush Grover

Doctor Piyush Grover (B.Pharm (Hons), MBBS (Hons1), FRACP) is a medical oncologist at Fiona Stanley Hospital, Perth, Western Australia, and a PhD candidate at the University of Western Australia. He is a clinician-researcher with interests in neuroendocrine tumours, upper gastrointestinal cancers, and melanoma. Dr Grover is undertaking a clinical PhD in Immuno-Oncology after completing a clinical and research fellowship at the Melanoma Institute Australia. Dr Grover is committed to holistic patient centred care, evidence-based practice, and education. Dr Grover has published several peer-reviewed articles including a first-author publication in the Annals of Oncology and presented at international conferences such as…
Read bio

A/Prof David Wyld

A/Prof David Wyld’s research interests have focused particularly on gastrointestinal cancers (with a specific focus on pancreatic cancer, colorectal cancer and neuroendocrine tumours (NETs)), gynaecologic malignancies and qualitative patient focused research. His current major research focuses are in the areas of NETS, Pancreatic Cancer, the supportive care needs of patients with cancer and health systems research. A/P Wyld has authored 2 book chapters and over 80 refereed publications, with approx. 50 in the last 5 years. Over the last 20 years as a full-time practicing Cancer Clinician at RBWH, A/P Wyld has maintained an active research focus, predominantly in the…
Read bio

Dr David Chan

David is a medical oncologist with a subspecialty interest in NETs. His PhD on PET scans as biomarkers in NENs was awarded in 2020, and he has been continuously supported by research funding since. He has published more than 100 peer-reviewed articles, more than 50 concerning NETs, and received more than $5 million AUD in peer-reviewed funding as a chief investigator. He serves as the chair of the NET group of the Clinical Oncology Society of Australia (2019-) and co-leads the NET centre of excellence based at Royal North Shore Hospital, Australia.
Read bio

A/Prof Gabrielle Cehic

Gabrielle brings over 30 years of experience in cancer care as a Nuclear Medicine Physician and Medical Oncologist, with a dedicated focus on Neuroendocrine Tumours. Based at The Queen Elizabeth Hospital in Adelaide, she continues to lead the expansion of precision oncology (Theranostics) services for South Australian and Northern Territory patients. She is committed to advancing survivorship, enhancing patient’s quality of life, and integrating multidisciplinary perspectives to improve outcomes. As a long-time supporter of Neuroendocrine Cancer Australia’s mission, Gabrielle values the foundation’s five pillar approach- support, education, research, awareness and advocacy. Her participation on the NECA Research Advisory Panel underlies…
Read bio

Prof Tim Price

Professor Tim Price is currently Head of Clinical Oncology Research at The Queen Elizabeth Hospital, Woodville. He is also the Chair of the SA Comprehensive Cancer Network Clinical Trials Program committee. He is Chair of the current Australian Cancer Council NHMRC Colorectal Guidelines committee. He is also a member of the COSA NET group and the South Australian state PRRT service. He has been involved in several NET research programs via the AGITG and COMMNETS. In addition, Prof Price is an associate editor for the British Journal of Cancer and ESMO Gastrointestinal Oncology.
Read bio

Dr John Leyden

Dr John Leyden is the co-founder NeuroEndocrine Cancer Australia and a specialist anaesthetist with clinical interests in cardiothoracic surgery, bariatric surgery and neuroendocrine cancers currently in practice at Royal North Shore Hospital, Sydney and in private practice. After obtaining his medical degree at Monash University he went on to specialise in anaesthesia, completing a cardiothoracic anaesthesia fellowship at the University of Toronto (Canada) and a Masters of Public Health and Masters of Medical Management at the University of New South Wales. Dr Leyden has numerous peer-reviewed publications and abstracts and has been an investigator in successful NHMRC grants. He is…
Read bio

Quick Links

Newly Diagnosed
Living with NETs
Optimal Care Pathway
Close

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.

Get Involved